Stock Spotlight: Waste Management Inc (NYSE:WM)


About Waste Management Inc


Waste Management, Inc., through its subsidiaries, provides environmental solutions to residential, commercial, industrial, and municipal customers in the United States, Canada, Western Europe, and internationally. It offers collection services, including picking up and transporting waste and recyclable materials from where it was generated to a transfer station, recovery facility, or disposal site; owns and operates transfer stations; and owns, develops, and operates landfill gas-to-energy facilities that produce renewable electricity and renewable natural gas. It also operates materials processing and commodities recycling services, including cardboard, paper, glass, metals, plastics, construction and demolition materials, and other recycling commodities are recovered for resale or redirected for other purposes; recycling brokerage services, such as managing the marketing of recyclable materials for third parties; and other strategic business solutions. In addition, the company collects recyclable food and yard waste, as well as markets and sells mulch, compost, soil amendments, and renewable energy; offers remediation and construction, and industrial waste services; and manages and markets fly ash. Further, it provides Regulated Waste and Compliance Services (RWCS), which offers compliance programs, as well as collection, processing, and disposal of regulated and specialized waste, including medical, pharmaceutical, and hazardous waste; and Secure Information Destruction (SID) services that includes the collection of personal and confidential information for secure destruction and recycling of sorted office paper. The company was formerly known as USA Waste Services, Inc. and changed its name to Waste Management, Inc. in 1998. Waste Management, Inc. was founded in 1968 and is based in Houston, Texas.


Key Stats

Data as of 11/12/25.


Price Performance


Growth Potential

  • Essential service (waste collection, recycling, disposal and landfill services) with recession-resilience gives the company a defensive tilt making it an attractive investment in an uncertain environment.
  • Structural industry tailwinds and high barriers to entry as waste and recycling industry is increasingly constrained by limited landfill capacity and regulatory hurdles for new disposal sites with the company owning hard-to-replicate assets (largest landfill network, transfer stations, fleets) while being vertically integrated (business model spans collection + transfer + landfill/disposal + resource recovery), provides benefit from pricing power across collection and disposal businesses.
  • Strong pricing power (fee increases, contract escalators) along with cost and efficiency improvements (deploying technology like route optimisation, newer trucks, side-loading equipment etc. to reduce labour/asset cost per unit of waste collected) gives ability to expand margins.
  • Strategic diversification and optionality in new growth areas with the company investing in renewable natural gas (RNG) from landfills and sustainable operations (command higher premium especially from ESG investors), consolidating through acquisitions and improving route efficiency via automation and technology (thus lowering cost base over time).
  • Disciplined capital allocation strategy with a focus to sustainably grow its dividend, targeting a 40-50% FCF payout, maintain capex at 9.5-10.5% of revenue and resume buybacks once the leverage returns to 2.5-3.0x.

Key Risks


  • Regulatory/environmental risks as landfills have long-term liabilities (closure, leachate, emissions) and increasing regulation (PFAS, waste diversion laws) which could increase capex or compliance costs.
  • Execution risk in growth initiatives (investing in RNG, recycling, M&A).
  • Cost/inflationary pressures from fuel, labor and equipment could squeeze margins.
  • Lower commodity prices (decline in OCC and RIN prices) could impact earnings.

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

December 12, 2025
A clear look at how rare earths drive EVs, wind power and AI hardware, and what supply constraints mean for long-term investment themes.
December 11, 2025
About Medtronic Plc Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland. Key Stats
December 11, 2025
The Fed’s latest rate cut marks a key shift in policy. Explore its impact on global markets, inflation risks, and how investors should position heading into 2026.
December 9, 2025
How U.S.–China competition in semiconductors shapes AI, manufacturing, and global markets, and what investors need to know.
December 5, 2025
Insights on the Fed’s next move, market implications and what investors should expect heading into 2026.
December 2, 2025
As December unfolds, explore the Santa Claus Rally and uncover its drivers, risks, and potential impact on investors this year.
November 21, 2025
About Xero Ltd Xero Limited, together with its subsidiaries, provides online business solutions for small businesses and their advisors in Australia, New Zealand, the United Kingdom, North America, and internationally. It offers accounting, payroll, payments and other solutions through its Xero platform. The company also provides Planday, an online employee scheduling software; Hubdoc for bills and receipts; Syft, which creates reports, forecasts, dashboards, and consolidations with AI insights; TaxCycle, a tax preparation software for accountants and bookkeepers; and Tickstar, an e-invoicing product. Xero Limited was incorporated in 2006 and is headquartered in Wellington, New Zealand. Key Stats
November 20, 2025
Discover why Centuria shares are a top ASX income stock, offering stable dividends & growth potential. Stay informed on Centuria’s opportunities & risks.
November 20, 2025
Fortescue Ltd (FMG) stock insights: Explore growth, dividends, risks & investor strategies for long-term returns. Read our complete Stock Spotlight today!
November 18, 2025
Stay updated on Westpac Banking Corporation (ASX:WBC) with stock updates, technical analysis, forecasts & insights. See if WBC aligns with your investment goals.